No recent analyst price targets found for MYNZ.
Latest News for MYNZ
Mainz Biomed NV (NASDAQ:MYNZ) Short Interest Update
Mainz Biomed NV (NASDAQ: MYNZ - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 255,354 shares, an increase of 47.4% from the December 31st total of 173,183 shares. Currently, 2.8% of the shares of the company are
Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
BERKELEY, Calif. and , Jan. 14, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V.
2 Small-Cap Biotechs That Could Reward Patient Investors
Speculative investors and patience rarely go hand in hand. Nevertheless, if you're looking to invest in the small-cap biotech sector, patience is a requirement.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MYNZ.
U.S. House Trading
No House trades found for MYNZ.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.